62638-06-6

Basic information

• Product Name: CYCLOHEXANE-1,3-DICARBOXYLIC ACID DIMETHYL ESTER
• Synonyms: CYCLOHEXANE-1,3-DICARBOXYLIC ACID DIMETHYL ESTER;diMethyl cyclohexane-1,3-dicarboxylate;Dimethyl 1,3-cyclohexane dicarboxylate
• CAS NO: 62638-06-6
• Molecular Formula: C₁₀H₁₆O₄
• Molecular Weight: 200.23
• Mol File: 62638-06-6.mol

Chemical Properties

• Boiling Point: 258.1±15.0℃ (760 Torr)
• Flash Point: 120.7±18.8℃
• Appearance: /
• Density: 1.102±0.06 g/cm3 (20 ºC 760 Torr)
• Refractive Index: 1.4592 (589.3 nm 18℃)
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: CYCLOHEXANE-1,3-DICARBOXYLIC ACID DIMETHYL ESTER(CAS DataBase Reference)
• NIST Chemistry Reference: CYCLOHEXANE-1,3-DICARBOXYLIC ACID DIMETHYL ESTER(62638-06-6)
• EPA Substance Registry System: CYCLOHEXANE-1,3-DICARBOXYLIC ACID DIMETHYL ESTER(62638-06-6)

Safety Data

• Hazardous Substances Data: 62638-06-6(Hazardous Substances Data)

Usage

Uses

Used in Polymer and Resin Production:
CYCLOHEXANE-1,3-DICARBOXYLIC ACID DIMETHYL ESTER is used as a key intermediate in the synthesis of polyester resins, which are extensively utilized in the production of coatings, adhesives, and packaging materials. Its properties contribute to the formation of durable and high-quality end products in these applications.
Used in Plasticizer Manufacturing for PVC Products:
In the manufacturing of PVC products, CYCLOHEXANE-1,3-DICARBOXYLIC ACID DIMETHYL ESTER serves as a plasticizer, enhancing the flexibility and workability of the final plastic products. This application is crucial for creating a wide range of consumer and industrial goods.
Used in Coatings Industry:
CYCLOHEXANE-1,3-DICARBOXYLIC ACID DIMETHYL ESTER is used as a component in the formulation of coatings, providing essential properties such as adhesion, durability, and resistance to various environmental factors. Its presence in coatings contributes to their performance and longevity.
Used in Adhesives Industry:
As a component in adhesive formulations, CYCLOHEXANE-1,3-DICARBOXYLIC ACID DIMETHYL ESTER contributes to the bonding strength and stability of adhesives, making them suitable for various applications, including industrial assembly and construction.
Used in Packaging Materials:
In the packaging industry, CYCLOHEXANE-1,3-DICARBOXYLIC ACID DIMETHYL ESTER is used in the production of materials that offer protection, durability, and resistance to the contents they hold. Its role in packaging materials ensures the safe and efficient distribution of products.
It is important to handle CYCLOHEXANE-1,3-DICARBOXYLIC ACID DIMETHYL ESTER with care due to its potential health and environmental hazards, ensuring safe practices in its production, use, and disposal.

Upstream product

• 67-56-1 methanol 
• 3971-31-1 cyclohexane-1,3-dicarboxylic acid 
• 684-93-5 1-methyl-1-nitrosourea 
• 121-91-5 isophthalic acid 
• 3971-28-6 cis-/trans-1,3-Bis(hydroxymethyl)cyclohexane 
• 1459-93-4 dimethyl Isophthalate 
• 27768-32-7 cyclohexane-1,3-dicarbonyl dichloride 
• 186581-53-3 diazomethane 
• 2495-35-4 benzylacrylate 
• 2409-87-2 methyl (2E)-penta-2,4-dienoate 
• 108162-40-9 3-hydroperoxy-3-methylbicyclo<3.3.1>nonane-2,4-dione 

Downstream Products

• 110371-27-2 bicyclo[3.2.1]octane-1,5-dicarboxylic acid monomethyl ester 
• 106004-11-9 dimethyl bicyclo<3.2.1>octane-1,5-dicarboxylate 
• 1383973-51-0 methyl 5-(benzyloxycarbonylamino)bicyclo[3.2.1]octane-1-carboxylate 
• 1383973-52-1 5-(benzyloxycarbonylamino)bicyclo[3.2.1]octane-1-carboxylic acid 
• 1383973-53-2 benzyl 5-aminobicyclo[3.2.1]octan-1-ylcarbamate 
• 1383973-54-3 benzyl (5-(3-fluorobcnzamido)bicyclo[3.2.1]octan-1-yl)carbamate 
• 1383973-50-9 N-(5-aminobicyclo[3.2.1]octan-1-yl)-3-fluorobenzamide 
• 1383973-78-1 methyl 5-aminobicyclo[3.2.1]octane-1-carboxylate 
• 1396379-54-6 benzyl 5-carbamoylbicyclo[3.2.1]octan-1-ylcarbamate 
• 1383973-81-6 benzyl 5-(2-methylpyrimidin-4-ylcarbamoyl)bicyclo[3.2.1]octan-1-ylcarbamate 
• 1383971-61-6 N,N'-(bicyclo[3.2.1]octane-1,5-diyl)bis(6-methylpicolinamide) 
• 1383971-60-5 N-(5-(3-chlorobenzamido)bicyclo[3.2.1]octan-1-yl)-6-methylpicolinamide 
• 57702-85-9 1,3-bis-bromomethyl-cyclohexane 
• 50738-62-0 methyl 3-formylcyclohexane-1-carboxylate 

Relevant articles and documents

Ultralow-Molecular-Weight Stimuli-Responsive and Multifunctional Supramolecular Gels Based on Monomers and Trimers of Hydrazides

The simpler, the better. A series of simple, neutral and ultralow-molecular-weight (MW: 140–200) hydrazide-derived supramolecular gelators have been designed and synthesized in two straightforward steps. For non-conjugated cyclohexane-derived hydrazides, their monomers can self-assemble to form gels through intermolecular hydrogen bonds and dipole-dipole interactions. Significantly, conjugated phthalhydrazide can self-aggregate into planar and circular trimers through intermolecular hydrogen bonds and then self-assemble to form gels through intermolecular π–π stacking interactions. It is interesting that these simple gelators exhibit unusual properties, such as self-healing, multi-response fluorescence, and visual and selective recognition of chiral (R)/(S)-1,1′-binaphthalene-2,2′-diamine and S2? through much different times of gel re-formation and blue-green color change, respectively. These results underline the importance of supramolecular gels and extend the scope of supramolecular gelators.

NOVEL 5 OR 8-SUBSTITUTED IMIDAZO [1, 5-a] PYRIDINES AS INDOLEAMINE AND/OR TRYPTOPHANE 2, 3-DIOXYGENASES

Disclosed herein are 5 or 8-substituted imidazo[l,5-a]pyridines and pharmaceutical compositions comprising at least one such 5 or 8-substituted imidazo[l,5-a]pyridines, processes for the preparation thereof, and the use thereof in therapy. Disclosed herein are certain 5 or 8- substituted imidazo[l,5-a]pyridines that can be useful for inhibiting indoleamine 2,3- dioxygenase and/or tryptophane 2,3-dioxygenase and for treating diseases or disorders mediated thereby.

BENZAMIDE IMIDAZOPYRAZINE BTK INHIBITORS

Provided are Bruton's Tyrosine Kinase (Btk) inhibitor compounds according to Formula I, pharmaceutically acceptable salts thereof, pharmaceutical compositions thereof, or their use in therapy.

Cis-Dichlorido(3,6,9-trithiabicyclo[9.3.1]pentadecane-κ2 S 3,S 6)palladium(II) acetonitrile 0.8-solvate

In the title complex, [PdCl2(C12H22S 3)]·0.8CH3CN, a potentially tridentate thioether ligand coordinates in a cis-bidentate manner to yield a square-planar environment for the PdII cation [mean deviation of the Pd from the Cl2S2 plane = 0.0406 (7) A]. Each square-planar entity packs in an inverse face-to-face manner, giving pairs with plane-to-plane separations of 3.6225 (12) A off-set by 1.1263 (19) A, with a Pd...Pd separation of 3.8551 (8) A. A partial acetonitrile solvent molecule is present. The occupancy of this molecule was allowed to refine, and converged to 0.794 (10). The synthesis of the previously unreported 3,6,9-trithiabicyclo[9.3.1]pentadecane ligand is also outlined.

BICARBOCYCLIC AND TRICARBOCYCLIC ETHYNYL DERIVATIVES AND USES OF SAME

The present invention provides compounds of formula (1): where R1, R2, X. Y and n are as described herein, and pharmaceutical compositions, uses and methods comprising same.

BICYCLO[3.2.1]OCTYL AMIDE DERIVATIVES AND USES OF SAME

The present invention provides bicyclo[3.2.1]octyl amide derivatives of formula (I): wherein L, R1 and R2 are as defined herein, or a pharmaceutically acceptable salt thereof; pharmaceutical compositions and methods using the same.

Pyridine derivatives

Pyridine compounds of general formula: wherein —R1represents in which R11is hydrogen, C1-6alkyl, halogen, hydroxy, C1-12alkoxy, nitro, amino, C1-6alkylsulfonylamino, C1-6alkoxycarbonyl, C1-6alkylamino, di(C1-6alkyl)amino, C1-6alkanoylamino, phenyl C1-6alkylamino, phenylsulfonylamino, or —O—(CH2)n—R111; R2represents hydrogen or halogen; R3represents hydrogen, —CR31R32R33, or —NR34R35; R4is hydrogen, carbamoyl, CN, carboxyl, etc.; R5is amino, C1-6alkylamino, di C1-6alkylamino, etc. or salt thereof. The compound has an excellent anti-inflammatory activity, and other biological activity.

Method for hydrogenating benzene polycarboxylic acids or derivatives thereof by using a catalyst containing macropores

A process for hydrogenating a benzenepolycarboxylic acid or a derivative thereof or a mixture of two or more thereof by bringing the benzenepolycarboxylic acid or the derivative thereof or the mixture of two or more thereof into contact with a hydrogen-containing gas is carried out in the presence of a catalyst which comprises as active metal at least one metal of transition group VIII of the Periodic Table alone or together with at least one metal of transition group I or VII of the periodic table applied to a support which contains macropores with the proviso that if dimethyl terephthalate is hydrogenated, the hydrogenation using a catalyst which comprises as active metal ruthenium either alone or together with at least one metal of transition group I, VII or VIII of the Periodic Table applied to a support, where the support has a mean pore diameter of at least 50 nm and a BET surface area of at most 30 m2/g and the amount of the active metal is from 0.01 to 30% by weight, based on the total weight of the catalyst, and the ratio of the surface areas of the active metal and the catalyst support is less than 0.05, and/or a catalyst which comprises as active metal ruthenium either alone or together with at least one metal of transition group I, VII or VIII of the Periodic Table in an amount of from 0.01 to 30% by weight, based on the total weight of the catalyst, applied to a support, where from 10 to 50% of the pore volume of the support is formed by macropores having a pore diameter in the range from 50 nm to 10,000 nm and from 50 to 90% of the pore volume of the support is formed by mesopores having a pore diameter in the range from 2 to 50 nm, where the sum of the pore volumes adds up to 100%, is excluded, and novel hydrogenation products, obtainable by hydrogenating benzenepolycarboxylic acid (derivatives) as well as their use as plasticizers in plastics.

Preparation of [2.2]-para-, meta-, and orf/ro-cyclophanes containing a 1, 3-cyclohexano group

[2.2]-para-, ineta-, and o/7/w-CycIophanes containing a 1, 3-cyclohexane ring bridged with two carbons were prepared through a coupling reaction to form dithiacyclophane, followed by oxidation to yield the sulfone and then pyrolysis.

Thiazolidinone compounds and composition for angina pectoris comprising the compounds as an active ingredient

A thiazolidinone compound represented by general formula (I) or a pharmacoligically acceptable salt thereof, STR1 wherein W represents sulfur or oxygen and X represents --N(R1)--, or alternatively X represents sulfur or oxygen and W represents --N(R1)--, and R1 represents hydrogen, alkyl or substituted alkyl; R2 and R3 are the same or different from each other, and each represents hydrogen, alkyl, substituted alkyl, aryl, or 5- or 6-membered heteroaryl; R4 represents hydrogen, alkyl or substituted C1 -C4 alkyl; R5 represents substituted cycloalkyl which may contain nitrogen, provided the substituents include --B--ONO2 (wherein B represents a single bond or alkylene) as the indispensable member and alkyl groups as optional members; and A represents a single bond or alkylene, has an excellent anti-anginal effect and thus is useful as an angina pectoris remedy or preventive.